Role of hydroxychloroquine in multidrug treatment of COVID-19

"Hydroxychloroquine is the most widely prescribed intracellular anti-infective for human SARS-CoV-2 infection and COVID-19 syndrome. There have been 296 studies, 220 of which are peer reviewed, 246 comparing treatment and control groups. This agent is successfully used in both prophylaxis and early therapy. As a general principle, the earlier hydroxychloroquine is started in the course of illness, the larger treatment effects can be observed. These effects are greatly enhanced by the use of agents in combination to address SARS-CoV-2 replication, cytokine storm, and thrombosis."